David Landman

7.7k total citations
83 papers, 6.3k citations indexed

About

David Landman is a scholar working on Molecular Medicine, Infectious Diseases and Pharmacology. According to data from OpenAlex, David Landman has authored 83 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Medicine, 28 papers in Infectious Diseases and 27 papers in Pharmacology. Recurrent topics in David Landman's work include Antibiotic Resistance in Bacteria (52 papers), Antibiotics Pharmacokinetics and Efficacy (27 papers) and Antimicrobial Resistance in Staphylococcus (23 papers). David Landman is often cited by papers focused on Antibiotic Resistance in Bacteria (52 papers), Antibiotics Pharmacokinetics and Efficacy (27 papers) and Antimicrobial Resistance in Staphylococcus (23 papers). David Landman collaborates with scholars based in United States, Canada and Czechia. David Landman's co-authors include John Quale, Simona Bratu, Claudiu Georgescu, Guillermo Saurina, Carl Urban, Steven E. Brooks, Antonella Eramo, Rose A. Recco, Robin Haag and Marie Abdallah and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

David Landman

81 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Landman United States 39 4.7k 2.2k 1.5k 1.4k 1.4k 83 6.3k
John Quale United States 40 4.7k 1.0× 2.2k 1.0× 1.5k 1.0× 1.4k 1.0× 1.5k 1.1× 108 6.6k
George L. Daikos Greece 40 4.5k 1.0× 2.4k 1.1× 1.2k 0.8× 1.4k 1.0× 2.1k 1.5× 136 6.8k
Federico Pérez United States 43 4.9k 1.0× 1.9k 0.9× 1.7k 1.1× 1.3k 0.9× 1.5k 1.1× 133 6.2k
Amy J. Mathers United States 34 4.0k 0.8× 1.4k 0.6× 1.7k 1.1× 1.2k 0.8× 1.1k 0.9× 101 5.5k
Andrea Endimiani Switzerland 46 5.7k 1.2× 1.7k 0.8× 2.3k 1.5× 1.1k 0.8× 1.5k 1.1× 156 7.2k
Spyros Pournaras Greece 46 4.9k 1.0× 1.6k 0.7× 2.1k 1.4× 1.0k 0.7× 1.7k 1.2× 221 7.6k
María Virginia Villegas Colombia 40 3.9k 0.8× 1.0k 0.5× 1.4k 1.0× 1.5k 1.0× 949 0.7× 129 5.4k
Mitchell J. Schwaber Israel 40 4.6k 1.0× 1.3k 0.6× 1.6k 1.1× 1.9k 1.4× 2.1k 1.5× 108 7.4k
Christine C. Sanders United States 47 4.6k 1.0× 2.5k 1.2× 1.4k 1.0× 936 0.7× 1.4k 1.0× 129 6.4k
Teresa Spanu Italy 43 3.5k 0.7× 1.4k 0.7× 965 0.6× 1.4k 1.0× 2.3k 1.7× 130 6.5k

Countries citing papers authored by David Landman

Since Specialization
Citations

This map shows the geographic impact of David Landman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Landman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Landman more than expected).

Fields of papers citing papers by David Landman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Landman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Landman. The network helps show where David Landman may publish in the future.

Co-authorship network of co-authors of David Landman

This figure shows the co-authorship network connecting the top 25 collaborators of David Landman. A scholar is included among the top collaborators of David Landman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Landman. David Landman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landman, David, Orit Gefen, Ayelet Michael-Gayego, et al.. (2025). Bactericidal activity of antibiotic combinations against clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus. Journal of Antimicrobial Chemotherapy. 80(6). 1519–1525.
2.
3.
Landman, David, et al.. (2021). Trends in Healthcare Facility-Onset Clostridioides difficile Infection and the Impact of Testing Schemes in an Acute Care Hospital System in New York City, 2016-2019. American Journal of Infection Control. 49(10). 1262–1266. 1 indexed citations
4.
Landman, David, et al.. (2020). Activity of Cefiderocol Against Enterobacterales , Pseudomonas aeruginosa , and Acinetobacter baumannii Endemic to Medical Centers in New York City. Microbial Drug Resistance. 26(7). 722–726. 45 indexed citations
5.
Landman, David, et al.. (2020). Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals. Microbial Drug Resistance. 27(2). 190–195. 17 indexed citations
6.
Rose, Michael T., et al.. (2019). In Vitro and In Vivo Activity of a Novel Antisense Peptide Nucleic Acid Compound Against Multidrug-Resistant Acinetobacter baumannii. Microbial Drug Resistance. 25(7). 961–965. 11 indexed citations
7.
8.
Landman, David, et al.. (2018). Group B Streptococcal Tricuspid Endocarditis: Case Report and Systematic Review.. PubMed. 2(4). 1 indexed citations
9.
Landman, David, et al.. (2017). In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 73(2). 431–436. 37 indexed citations
10.
Landman, David, Paul Kelly, Martín Bäcker, et al.. (2010). Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. Journal of Antimicrobial Chemotherapy. 66(2). 332–334. 78 indexed citations
11.
Sharma, Roopali, George Allen, David Landman, et al.. (2009). Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae. Infection Control and Hospital Epidemiology. 30(5). 447–452. 157 indexed citations
12.
Bratu, Simona, David Landman, Robin Haag, et al.. (2005). Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City. Archives of Internal Medicine. 165(12). 1430–1430. 466 indexed citations
13.
Landman, David. (2005). Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. Journal of Antimicrobial Chemotherapy. 55(6). 954–957. 101 indexed citations
14.
Quale, John, et al.. (2002). Molecular Epidemiology of a Citywide Outbreak of Extended‐Spectrum β‐Lactamase–Producing Klebsiella pneumoniae Infection. Clinical Infectious Diseases. 35(7). 834–841. 82 indexed citations
15.
Landman, David, et al.. (2000). Endemic Carbapenem-Resistant Acinetobacter Species in Brooklyn, New York: Citywide Prevalence, Interinstitutional Spread, and Relation to Antibiotic Usage. Clinical Infectious Diseases. 31(1). 101–106. 257 indexed citations
16.
Landman, David, Guillermo Saurina, & John Quale. (1998). Failure of All Antifungal Therapy for Infection Due toCandida albicans. A New AIDS‐Related Problem?. Clinical Infectious Diseases. 26(1). 183–184. 13 indexed citations
17.
Quale, John, et al.. (1998). Deja vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. The American Journal of Medicine. 105(4). 296–301. 37 indexed citations
18.
Landman, David. (1997). Management of infections due to resistant enterococci: a review of therapeutic options. Journal of Antimicrobial Chemotherapy. 40(2). 161–170. 90 indexed citations
19.
Landman, David, et al.. (1996). Rapid Development of Renal Insufficiency with the Simultaneous Administration of Amphotericin B and Foscarnet. Clinical Infectious Diseases. 22(2). 378–378. 3 indexed citations
20.
Mobarakai, Neville, David Landman, & John Quale. (1994). In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 33(2). 319–321. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Quale Breakdown of academic impact, for papers by George L. Daikos Breakdown of academic impact, for papers by Federico Pérez Breakdown of academic impact, for papers by Amy J. Mathers Breakdown of academic impact, for papers by Andrea Endimiani Breakdown of academic impact, for papers by Spyros Pournaras Breakdown of academic impact, for papers by María Virginia Villegas Breakdown of academic impact, for papers by Mitchell J. Schwaber Breakdown of academic impact, for papers by Christine C. Sanders Breakdown of academic impact, for papers by Teresa Spanu
Rankless by CCL
2026